Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

The PREFECT study


The PREFECT was launched in 2013. Electroconvulsive therapy (ECT) is a highly effective treatment for depression. However, not all patients respond to the therapy and some experience side effects. More knowledge is needed to determine who and what indication is most likely to benefit from the treatment. The aim of the study is to identify factors that help predict which individuals are most likely to respond to ECT treatment and which individuals that are more likely to benefit from other treatment forms. We aim to identify both genetic and blood borne markers for ECT response and side effects. The overarching aim is to develop tools that can be used to tailor the psychiatric treatment for individual patients.

The study has been approved by the Regional ethical committee in Stockholm (ref no 2012/169-31/1) and is funded by the Swedish Foundation for Strategic Research. The study is coordinated from Karolinska Institutet, Department of Medical Epidemiology and Biostatistics.

Page Manager: Webbredaktör|Last update: 10/26/2016
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?